找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biologic Therapy of Leukemia; Matt Kalaycio Book 2003 Springer Science+Business Media New York 2003 antibody.cytokine.cytokines.dendritic

[復(fù)制鏈接]
樓主: Blandishment
41#
發(fā)表于 2025-3-28 17:22:56 | 只看該作者
42#
發(fā)表于 2025-3-28 20:06:47 | 只看該作者
Franz J. Frei,Thomas Erb,Robert Sümpelmann.. Gene therapy approaches can be divided into the manipulation of reproductive cells to maintain a genetic modification in future generations (germ-line gene therapy) or gene transfer into more differentiated tissues, such as cells of the lung, liver, or brain, or hematopoietic cells (somatic gene
43#
發(fā)表于 2025-3-29 02:02:29 | 只看該作者
Antisense Therapyolecular biology of leukemia has identified a series of target genes whose protein products are integral to the pathogenesis of leukemia. Much of this insight has initially been garnered from cytogenetic observations and clinical correlations. These sentinel discoveries have been bolstered by the availability of genomic and proteomic screening.
44#
發(fā)表于 2025-3-29 04:32:03 | 只看該作者
F. J. Frei,C. Jonmarker,O. WernerMonoclonal antibodies (MAbs) have been studied as a treatment for leukemia for approximately 20 years but have only recently been used successfully. The history of MAb development has been reviewed extensively .. The purpose of this chapter is to review the clinical data supporting the use of unconjugated MAbs in the treatment of leukemia.
45#
發(fā)表于 2025-3-29 09:03:14 | 只看該作者
Unconjugated Monoclonal AntibodiesMonoclonal antibodies (MAbs) have been studied as a treatment for leukemia for approximately 20 years but have only recently been used successfully. The history of MAb development has been reviewed extensively .. The purpose of this chapter is to review the clinical data supporting the use of unconjugated MAbs in the treatment of leukemia.
46#
發(fā)表于 2025-3-29 14:50:40 | 只看該作者
47#
發(fā)表于 2025-3-29 15:57:42 | 只看該作者
48#
發(fā)表于 2025-3-29 19:46:00 | 只看該作者
Matt KalaycioIncludes supplementary material:
49#
發(fā)表于 2025-3-30 01:59:56 | 只看該作者
50#
發(fā)表于 2025-3-30 04:32:00 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 08:26
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
西平县| 仁怀市| 沭阳县| 通许县| 绥宁县| 尚志市| 工布江达县| 肇州县| 岳池县| 乌什县| 三原县| 通江县| 闽侯县| 平塘县| 安塞县| 吉安县| 娱乐| 沂源县| 贵南县| 友谊县| 察雅县| 仁怀市| 天全县| 新巴尔虎左旗| 柳林县| 成武县| 嘉峪关市| 遂宁市| 玉树县| 泸定县| 佛山市| 行唐县| 满洲里市| 武城县| 高雄县| 汉源县| 神木县| 专栏| 交城县| 元朗区| 辽阳县|